Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_000277.3(PAH):c.535T>C (p.Tyr179His)

Curation Version - 1.0
Curation History
JSON LD for Version 1.0

CA229615

102730 (ClinVar)

Gene: PAH

Condition: phenylketonuria

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: 322ac92c-85df-4b41-b751-f5b2b91fb875

Approved on: 2022-12-09

Published on: 2022-12-09

HGVS expressions

NM_000277.3:c.535T>C

NM_000277.3(PAH):c.535T>C (p.Tyr179His)

NC_000012.12:g.102855307A>G

CM000674.2:g.102855307A>G

NC_000012.11:g.103249085A>G

CM000674.1:g.103249085A>G

NC_000012.10:g.101773215A>G

NG_008690.1:g.67296T>C

NG_008690.2:g.108104T>C

ENST00000553106.6:c.535T>C

ENST00000307000.7:c.520T>C

ENST00000549111.5:n.631T>C

ENST00000551988.5:n.556T>C

ENST00000553106.5:c.535T>C

NM_000277.1:c.535T>C

NM_000277.2:c.535T>C

NM_001354304.1:c.535T>C

NM_001354304.2:c.535T>C

Likely Pathogenic

PM3_Strong PP3 PP4_Moderate PM2

PM5

Evidence Links 0

Expert Panel

Phenylketonuria VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Phenylketonuria VCEP

The c.535T>C (p.Tyr179His) variant in PAH has been reported in multiple individuals with PKU, including in patients with classic PKU in whom BH4 deficiency has been excluded (PMID: 29997390, PMID: 16256386, PMID: 20920871, PMID: 32668217, PMID: 30389586). p.Tyr179His has been detected with multiple variants classified as likely pathogenic or pathogenic by PAH VCEP, including p.Arg176*, c.1066-11G>A, c.1199+1G>C, p.Ala403Val, p.Ile406Met, p.Arg408Trp, p.Val230Ile (PMID: 32668217). This variant is absent from population databases. Multiple lines of computational evidence support a deleterious effect. In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM3_Strong, PM2, PP4_Moderate, PP3.

PM3_Strong

PM3_Strong applies based on Hillert cases. Some of the previous papers may represent the same patients described in the Hillert paper. There are 7 compound heterozygous cases (with phase unconfirmed, so 3.5 pts)

PP3

Damaging in SIFT, PP-2, MutationTaster, REVEL=0.964

PP4_Moderate

Observed on at least 12 alleles, classic PKU for at least 6 cases when type described. At least 2 cases of compound heterozygotes with serum PAH >1200 μmol/L and BH4 deficiency excluded.

PM2

Absent from controls in ExAC, gnomAD, 1000 Genomes, or ESP

PM5

Y179N is LP in ClinVar

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.